Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery
- 1 February 2007
- journal article
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 54 (2) , 107-113
Abstract
Cardiac surgery with cardiopulmonary bypass requires systemic anticoagulation, defined by an activated clotting time (ACT) of 400–480 sec. Patients with altered heparin responsiveness require disproportionately higher doses of heparin to achieve this target ACT. A common risk factor for heparin resistance is preoperative heparin therapy. Recently, therapy with low molecular weight heparin (LMWH) has become an acceptable substitute for prolonged heparin therapy. The current study examines the effect of preoperative LMWH therapy on subsequent heparin responsiveness during cardiac surgery. Records of patients undergoing cardiac surgery with cardiopulmonary bypass over a period of four months were reviewed. We identified patients who, during the week preceding surgery, had received prolonged (> 24 hr) therapy with eithersc LMWH (LMWH group) or continuousiv unfractionated heparin (Heparin group). A Control group consisted of patients who received neither heparin nor LMWH preoperatively. The heparin sensitivity index (calculated as the first change in ACT from baseline divided by the first intraoperative heparin dose, normalized to body weight), was compared among groups using ANOVA. One hundred and thirty-nine patients were included in the analysis. The heparin sensitivity index was 33–45% higher in the Control group (1.6 ± 0.7 sec·IU−1·kg−1;P < 0. 0001) compared to the LMWH (1.2 ± 0.4 sec·IU−1·kg−1) and Heparin (1.1 ± 0.5 sec·IU−1·kg−1) groups. In a multivariable model, the use of preoperative LMWH remained a significant predictor of reduced intraoperative heparin responsiveness (P = 0.002). Prolonged preoperative LMWH therapy, similar to the known effect of prolonged unfractionated heparin infusion, reduces subsequent intraoperative response to heparin. La chirurgie cardiaque sous circulation extra-corporelle nécessite une anti-coagulation systémique, définie par un temps de coagulation activé (TCA) de 400–480 sec. Les patients présentant une réponse modifiée á l’héparine nécessitent des doses nettement plus importantes d’héparine pour atteindre le TCA cible. Un facteur de risque commun de la résistance á l’héparine est la thérapie préopératoire à l’héparine. L’héparine à bas poids moléculaire (HBPM) est récemment devenue un substitut approprié des thérapies prolongées à l’héparine. Cette étude porte sur l’effet de thérapies préopératoires HBPM sur la réaction à l’héparine durant la chirurgie cardiaque. Les dossiers de patients subissant une chirurgie cardiaque sous circulation extra-corporelle sur une période de quatre mois ont été étudiés. Les patients ayant suivi une thérapie prolongée ( 0,0001) que dans les groupes HBPM (1,2 ± 0,4 sec·IU−1·kg−1) et Héparine (1,1 ± 0,5 sec·IU−1·kg−1). Dans un modèle multivarié, l’utilisation de HBPM préopératoire demeure un indice prédicteur significatif de réponse diminuée à l’héparine intra-opératoire (P=0,002). Une thérapie préopératoire prolongée à l’HBPM, comme l’effet connu d’une perfusion prolongée d’héparine non-fractionnée, réduit la réponse intra-opératoire à l’héparine.Keywords
This publication has 33 references indexed in Scilit:
- Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?Perfusion, 2001
- DOES AGE INFLUENCE THE COAGULATION RESPONSE TO A DOSE OF HEPARIN?Anesthesia & Analgesia, 1999
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Antithrombin III During Cardiac SurgeryAnesthesia & Analgesia, 1997
- Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulationThe Annals of Thoracic Surgery, 1994
- Heparin resistance after preoperative heparin therapy or intraaortic balloon pumpingThe Annals of Thoracic Surgery, 1994
- Heparin Resistance prior to Cardiopulmonary BypassAnesthesiology, 1986
- Fresh Frozen Plasma: A Solution to Heparin Resistance during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1984
- Activated Coagulation Time Method for Control of Heparin is Reliable during Cardiopulmonary BypassAnesthesiology, 1984
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977